-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Guide: After the completion of this transaction, Fosun Pharmaceuticals will hold a total of about 61.044 percent of Chongqing Pharmaceutical Friends. On September 8, Fosun Pharma announced that fosun Pharmaceuticals, a controlling subsidiary, had signed an "equity transfer agreement" with the Employees' Shareholding Association, and that Fosun Pharmaceuticals intended to transfer about 10.044 percent of Chongqing Pharmaceutical Friends' shares for RMB742 million.
The consideration of this transaction is based on the vertical integration of Chongqing Pharmaceutical Friends in raw materials, preparations and research and development layout, product market share, etc., with reference to Chongqing Pharmaceutical Friends audited 2019 net profit attributable to the owner of the parent company (i.e. RMB739.1 million) 10 times, after consultation between the two parties to the transaction.
the completion of this transaction, Fosun Pharmaceuticals will hold a total of approximately 61.044% of Chongqing Pharmaceutical Friends, which remains a controlling subsidiary of the Company.
, Chongqing Pharmaceutical Friends was founded in July 1997, registered in Chongqing, China, the legal representative is Liu Qiang.
Chongqing Pharmaceutical Friends' business scope includes the production and sale of hard capsules, granules, dispersants, raw materials, sterile raw materials, large-capacity injections, tablets, freeze-dried powder needles, powder needles, small-capacity injections, pharmaceutical accessories, imported pharmaceutical sub-packaging (in accordance with the license approved period for business); Export business of products and technologies produced by the enterprise, import business of raw materials, instrumentation, machinery and equipment, spare parts and technology required for the production of the enterprise, research and development and technology transfer of pharmaceuticals, food, health care products, pharmaceutical intermediates, production of pharmaceutical intermediates, medical information consulting services (projects for which the above business scope is subject to approval in accordance with the law, and before the relevant departments may carry out business activities).
date of this announcement, the registered capital of Chongqing Pharmaceutical Friends was RMB196.54 million.
.